glp 1 agonist overdose GLP-1 Drug Glucagon-like peptide-1 receptor agonists and

Lee, S.Y

Gastrointestinal effects remain the most common complaint

The extended release microsphere formulation provides sustained exenatide levels throughout the week producing effective glycemic control and modest weight loss

Following the withdrawal of albiglutide from the market in 2018 by the manufacturer for financial reasons (257), liraglutide, injectable semaglutide, and dulaglutide should currently be the preferred choices within this class for reducing cardiovascular events until further data are available (248)

absolute values given in Supplementary Fig

[PubMed] [Google Scholar] 443.Pippig S., Andexinger S., Lohse M.J